Interventional Glaucoma

Consuming one cup of caffeinated coffee statistically increases IOP and ocular perfusion pressure (OPP) in primary open-angle glaucoma (POAG) patients.

SD-OCT imaging and retinal nerve fibre layer (RNFL) assessment successfully detects pre-perimetric glaucomatous damage.

Anterior chamber depth (ACD) and anterior chamber angle (ACA) were the factors identified relating to the progression of open-angle glaucoma (OAG).

IOP is successfully reduced with both trabeculectomy and combined trabeculotomy-trabeculectomy with mitomycin C in children with glaucoma.

Macular ganglion cell complex (mGCC) and peripapillary retinal nerve fiber layer (ppRNFL) thickness can be used as structural parameters for detecting preperimetric glaucoma.

Fight for Sight has donated £1.6 million towards ten research grants focused on tackling sight loss and eye disease treatment.

Vascular endothelial growth factor (VEGF) levels in the Tenon tissue and final IOP is significantly correlated to 1-year surgical outcomes of glaucoma surgery in patients with primary open-angle glaucoma (POAG)

Incidence of bleb-related infection (BRI) is higher in Mitomycin C (MMC) augmented trabeculectomy but is reduced to a lower level.

Conducting a modified dark room provocative test (DRPT) is better for the diagnosis of primary angle closure, compared to gonioscopic angle assessment.

Using a sterile, disposable barrier for the G-probe transsceleral cyclophotocoagulation (TSCPC) device is a safe and effective method of preventing contamination in consecutive patients.

Ever-widening knowledge base proves that there's more to it than controlling IOPs.

Baerveldt device showed better outcomes but required more interventions then Ahmed valve.

Dr Soloway discusses a novel approach for treating glaucoma known as the scleral spacing procedure (SSP) using PresView Scleral Implants

Performance compares favourably with trabeculectomy, in physician's experience

Strategy can improve patient compliance with glaucoma medication regimens.

Animals studies for neuroprotection in glaucoma have produced some promising results.

Dr Matthias Grieshaber advises surgeons to implement this technique into their armamentarium.

Results of an in vitro study of the potentially adverse efefcts of five different topical glaucoma medications and preservatives are revealed

Alternatives for reducing preservative loads must be considered when assessing the ocular surface of patients being treated in the long-term with IOP-lowering medications

A specific diode laser is the latest technology to perform several different laser procedures in the ophthalmic practice. Its multi-use capabilities for glaucoma and retinal disease make it a strong choice for the office setting.

There are still many challenges facing clinicians in the regeneration of the optic nerve. Dr M. Francesca Cordeiro reveals encouraging research results to help overcome these barriers.

Endoscopic cyclophotocoagulation combined with pars plana vitrectomy is a safe and highly effective technique for treating elevated IOP in pseudophakic eyes.

Dr Claes Feinbaum investigates emerging evidence that CCT is an important predictor for the development of primary open-angle glaucoma (POAG), and that it may be relevant as a predictor of both glaucoma progression and response to IOP-lowering medication

Implanatation of multiple trabecular micro-bypass implants (iStent, Glaukos) in Schlemm's canal following phamoemulsification successfully and significantly reduced IOP for 12 months after implantation, as well as the number of medications required to maintain target IOP

Analyses of data from the Confocal Scanning Laser Ophthalmoscopy Ancilliary Study to the Ocular Hypertension Treatment study found rim area parameters changed significantly in the eyes that had progression to a primary open-angle glaucoma endpoint compared with eyes that did not.